DEXYANE MeD

Palpebral

Medical device

  • Treats and limits the recurrence of eczema lesions.
  • Treats and limits the recurrence of eczema lesions. Tested under dermatological control.
  • prod1
  • Anti-eczema
  • Palpebral
    • Palpebral
    • Palpebral
    • Palpebral
    • Palpebral

      DEXYANE MeD

      Palpebral

      Medical device Treats eczema lesions - Decongests - Soothes - Soothes itchiness

      A medical device that treats atopic or contact eczema on the eyelids.

      • Treats and limits the recurrence of eczema lesions.
      • Treats and limits the recurrence of eczema lesions. Tested under dermatological control.
      Points of sale

      Usable by Infants - Children - Family - Adults

      Age From 3 month(s)

      Suitable Eyelids

      Skin type Eyelid eczema

      Need Anti-eczema

      Made in France

      DEXYANE MED Palpebral is a medical device* for treating localised atopic and/or contact eczema on the eyelids.
      Its formula, specially adapted to respect the delicate skin of the eyelids, acts as a semi-occlusive surface film on top of the skin, helping to repair the skin barrier.
      It instantly relieves and decongest, soothes itching and pain, reduces redness and irritation.
      DEXYANE MED Palpebral restores the altered skin barrier and corrects dryness.
      It can be used as a stand alone treatment, in combination with, or as a follow-up to topical corticosteroids.

      Benefit

      DEXYANE MED Palpébral relieves inflammatory eczema lesions on the eyelids.

      Benefits

      • SOOTHES itching
      • RELIEVES immediately and decongests
      • LIMITS the recurrence of eczema lesions

      Product scent

      Fragrance-free

      Emballage ne contenant pas de matière recyclée
      Emballage non recyclable

      *DEXYANE MED Palpebral is a medical device indicated for the treatment for eyelid, atopic or contact eczema. These eczemas are characterized by an altered skin barrier with a high risk of reaction (dryness, irritations, itching) to allergens and irritant agents.
      Read carefully the instructions for use before utilisation. Ask your pharmacist for advice. Conditions of availability and instructions for use may vary per country.
      CE 0459. Manufacturer: PIERRE FABRE MEDICAMENT, Les Cauquillous, 81500 LAVAUR, FRANCE

      *DEXYANE MED Palpebral is a medical device, a regulated health product which carries, in accordance with this regulation, the CE mark. Carefully read the instruction leaflet provided. Do not use if pregnant or breastfeeding. Avoid direct contact with the eyes. Age 3 months and up. Manufacturer : Pierre Fabre Medicament.

      The Green Impact Index is a tool displaying the environmental and societal impact of cosmetics, dietary supplements and wellness and family health products, based on the methodology of the AFNOR Spec 2215. Developed thanks to the contribution of 22 companies, associations and federations, it assesses your products on more than 50 criteria for ever greater transparency!

      Understanding the Green Impact Index

      Green impact index: C

      Environmental impact

      Formula

      Note Formula : B

      Biodegradable formula*
      85.0% natural origin ingredients
      *According to a OECD 301 test or Biodegradability index method

      Packaging

      Note Packaging : D

      Not recyclable packaging

      Manufacturing

      Note Manufacturing : B

      Made and packaged in a factory certified for the environment***
      ***according to ISO 14001 and/or 50001 standards

      Transportation

      Note Transportation : D

      Societal impact

      Societal impact

      Note Societal impact : B

      Product manufactured and packaged in a factory meeting French social standards
      Ducray is a brand of the Pierre Fabre Group, certified at the highest Exemplary level of AFNOR Certification’s Committed to CSR and Responsibility Europe labels, thus consolidating a long-standing commitment to contributing to sustainable development.

      Application

      Frequency of use

      2 times a day

      • Apply twice a day a thin layer directly to inflammatory eczema eyelid lesions with a clean finger, avoiding any contact with the eye.
      • For external use only.
      • Can be used as stand-alone treatment, in combination with or following topical corticosteroids.
      • When combined with a topical corticosteroid, apply the topical corticosteroid and wait a few minutes (5-15 minutes) before applying DEXYANE MED Palpebral.
      • Ask your doctor for advice for the use of DEXYANE MED Palpebral with the topical corticosteroid prescribed for babies ≥ 3 months and children. If the symptoms are not resolved after 3 weeks of treatment, consult a doctor.

      Contraindications to the use : Do not use in case of allergy to one of the ingredients. In the absence of available data, do not use during pregnancy or while breastfeeding.

      Precautions for use:
      • In case of allergic reaction, consult a doctor.
      • Avoid direct contact with the eyes.
      • Keep out of reach of children.
      • Close the tube carefully after use.
      • Cutaneous application site reactions (burning sensation, stinging, redness, itching, dryness, swelling, skin exfoliation…) are expected in subjects with eczema because these subjects present an altered skin barrier.
      • It is possible to observe a temporary aggravation of eczema.
      • If no improvement or in case of worsening of eczema symptoms within 8 to 10 days, consult a doctor.
      • If any doubt and/or any undesirable side effects linked to the use of this product, consult a doctor.
      • If you have reason to believe that a serious incident occurred linked to the use of this product, please report it to your national authority and to the manufacturer.

      Ingredients

      AQUA. GLYCERIN. CAPRYLIC/CAPRIC TRIGLYCERIDE. BUTYLENE GLYCOL. POLYSORBATE 60. GLYCERYL STEARATE. BUTYROSPERMUM PARKII (SHEA) BUTTER. CERA ALBA. PEG-100 STEARATE. 10-HYDROXYDECENOIC ACID. CAPRYLYL GLYCOL. CETYL ALCOHOL. CITRIC ACID. GLYCYRRHETINIC ACID. GUANIDINE CARBONATE. POLYACRYLATE-13. POLYISOBUTENE. POLYSORBATE 20. SCLEROTIUM GUM. SORBITAN ISOSTEARATE

      The consumer is advised to systematically check the composition of the product before purchasing it.

      Results

      • Immediately¹ after application : itching reduced
      • After 3 days¹ : improvement clinical signs, particularly burning sensations when used alone, based on patients' assessment

        ¹Clinical study to assess the tolerance and efficacy of Dexyane Med Palpebral applied three weeks twice daily (morning and evening) on palpebral lesions in 55 adults with mild to severe eyelid eczema, divided into 2 groups (alone, n=33 or in association with a topical treatment, n=22).
        Primary objective: global tolerance of Dexyane Med Palpebral on AD palpebral lesions, assessed by the investigator at D22, rated on a 5-point grading scale in both groups.
        Results: global tolerance assessed at D22 by investigator: Excellent (35%), Very good (36%), Good (11%), Moderate (5%), Bad (13%)
        Loading...